Adrenal insufficiency in non-transfusion-dependent α-thalassemia.
Nipapan JoradolVichit SupornsilchaiSomlak TongmeeseeBenjamas TanyongYodkwan AphikulchatkitDarintr SosothikulPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2017)
The prevalence of biochemical AI in α-thalassemia patients was similar to rates previously reported for NTD β-thalassemia. Annual screening for AI in α-thalassemia patients is recommended, and glucocorticoid replacement should be considered in NTD α-thalassemia patients with AI during critical illness.